Morphology, tumor grade, presence of hormone receptors (HR) and expression of the human epidermal growth factor receptor type 2 (HER2/neu) are further important prognostic factors of BRC with regard to disease recurrence and survival[7,8,9,10,11,12,13]. This evidence concerns the gene ERBB2 and neoplasm.